EU CHMP approves Merck’s KEYTRUDA as Adjuvant Treatment for patients (≥12 Years) With Stage…
Merck, today, announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA, Merck’s!-->…
Read More...
Read More...